Purpose: We aimed to evaluate the feasibility and safety of ultrasound-guided vacuum-assisted breast biopsy system for the treatment of intraductal papilloma (IDP). A vacuum-assisted breast biopsy system mammotome ® was recently introduced for simultaneous biopsy and excision of benign breast masses. Mammotome excision has the advantages of safety and less scar formation compared to open biopsy. Wide excision is a standard treatment for IDP of the breast. Methods: We retrospectively reviewed the clinical data by using the electric medical records of 752 cases of breast masses that were treated via Mammotome excision performed by a single surgeon between January 2007 and December 2012. Among these patients, 26 patients were diagnosed with benign IDP as indicated in the final pathologic reports. Results: The median follow-up period was 56.2 months (range, 29-92 months). Two patients were diagnosed with another IDP during the follow-up period. However, no recurrence was detected at the previous excision site, but new primary lesions were confirmed at another quadrant. Conclusion: We suggest that ultrasound-guided vacuum-assisted breast biopsy system may be feasible and safe for the treatment of IDP. 
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